DEADLINE ALERT for GRPN and WORX: The Law Offices of Frank

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
168
DEADLINE ALERT for GRPN and WORX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, June 27, 2020 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion.

Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to fcruz@frankcruzlaw.com .

Groupon, Inc. (NASDAQ: GRPN ) Class Period:   November 4, 2019 – February 18, 2020 Lead Plaintiff Deadline:  June 29, 2020

The complaint filed in this class action alleges that throughout the Class Period, Groupon made materially false and/or misleading statements, as well as failed to disclose material adverse facts about its business, operations, and prospects.  Specifically, Groupon failed to disclose to investors: (1) that Groupon was experiencing fewer customer engagements in its Goods category; (2) that Groupon relied on its Goods category to drive its sales, especially during the holiday season; (3) that, as a result of the foregoing, Groupon was likely to experience reduced sales; and (4) that, as a result of the foregoing, Groupon’s positive statements about its business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

SCWorx Corp. (NASDAQ: WORX ) Class Period:  April 13, 2020 – April 17, 2020 Lead Plaintiff Deadline:  June 29, 2020

Shareholders with $50,000 in losses or more are encouraged to contact the firm

The complaint filed in this class action alleges that throughout the Class Period, SCWorx made materially false and/or misleading statements, as well as failed to disclose material adverse facts about its business, operations, and prospects.  Specifically, SCWorx failed to disclose to investors: (1) that SCWorx’s supplier for COVID-19 tests had previously misrepresented its operations; (2) that SCWorx’s buyer was a small company that was unlikely to adequately support the purported volume of orders for COVID-19 tests; (3) that, as a result, SCWorx’s purchase order for COVID-19 tests had been overstated or entirely fabricated; and (4) that, as a result of the foregoing, SCWorx’s positive statements about its business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Follow us for updates on Twitter: twitter.com/FRC_LAW .

To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.  If you wish to learn more about these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com , or visit our website at www.frankcruzlaw.com .  If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

The Law Offices of Frank R. Cruz, Los Angeles Frank R. Cruz, 310-914-5007 fcruz@frankcruzlaw.com www.frankcruzlaw.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Natus Medical Enhances InVisus Pro NMUS Integration features

Updated Category News Views 157

Natus Medical's New Integration for Enhanced User Experience Natus Medical Incorporated has recently introduced a noteworthy development within its product line. The integration of the InVisus Pro Neuromuscular Ultrasound system with Natus Elite Software is a significant enhancement for EMG system users. This innovation enables a seamless connection between the InVisus...

Continue Reading
Innovative Uber Campaign by It's a 10® Haircare Captivates Consumers

Updated Category News Views 240

It’s a 10® Haircare Unveils Dynamic Advertising Strategy It's a 10® Haircare, a renowned professional haircare brand, has taken an exciting leap into innovative advertising with their recent Uber campaign. This unique initiative not only elevates the brand's visibility but also connects directly with beauty enthusiasts who frequent major retail outlets. Engaging...

Continue Reading
Essential Update on Cohen & Steers Quality Income Realty Fund

Updated Category News Views 85

Cohen & Steers Quality Income Realty Fund Overview In this article, we dive into the details regarding the distribution sources for Cohen & Steers Quality Income Realty Fund, Inc. (RQI). This information is crucial for current shareholders as it directly impacts their investment decisions and overall understanding of the fund's financial performance. Understanding Managed...

Continue Reading
Maggie Q's ActivatedYou Morning Complete Reaches Milestone Sales

Updated Category News Views 402

Understanding the Success of ActivatedYou Morning Complete Maggie Q's ActivatedYou has recently celebrated a remarkable achievement, hitting over 5 million units sold of their flagship product, Morning Complete. This milestone is a testament to the product's appeal and the effectiveness that many consumers have experienced. What is ActivatedYou Morning Complete? Morning...

Continue Reading
New Stad Center Aims to Transform Pediatric Pain Management

Updated Category News Views 360

Transforming Pediatric Pain Management with Integrative Approaches The Stad Center for Pediatric Pain, Palliative and Integrative Medicine at UCSF Benioff Children's Hospitals has recently launched a groundbreaking facility. This innovative center blends Eastern and Western medicine to provide a comprehensive care approach for children experiencing pain and serious...

Continue Reading